Form D · Biotechnology
Gila Therapeutics, Inc.
Edina, MN · CIK 0001673503
Offering snapshot reported Dec 6, 2023 · SEC filing
- Reported sold
- $400K Offering amount: $10M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 6, 2023 | Initial | $399,572 | No comparison | 7 | SEC filing |
| Nov 29, 2022 | Initial | $355,522 | No comparison | 6 | SEC filing |
| Nov 12, 2021 | Amendment | $1,250,000 | $848,066vs Feb 16, 2021 | 28 | SEC filing |
| Feb 16, 2021 | Initial | $401,934 | No comparison | 17 | SEC filing |
| Mar 13, 2019 | Initial | $314,434 | No comparison | 3 | SEC filing |
| Apr 18, 2017 | Amendment | $3,344,885 | $760,161vs May 2, 2016 | 33 | SEC filing |
| Feb 13, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 2, 2016 | Initial | $2,584,724 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498961
Source: Form D, filed Dec 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andres Acosta | Promoter |
| Timothy Barberich | Director |
| Michael R. Cardenas | Promoter |
| Christopher De Souza | Director |
| Jon Freeman | Executive |
| Richard Horan | Director |
| Sangeeta Kashyap | Executive |
| Scott Schorer | Director, Executive |
| Praveen Tyle | Director |
| Tom Vasicek | Executive |
| Thomas Vasicek | Executive |
| Sergei Zolutukhin | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5420 Highwood Drive West
Edina, MN, 55436
Edina, MN, 55436